retatrutide phase 2 trial obesity triple agonist Retatrutide, a (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Great news again!!! A phase

In conclusion, MNs/GLP-1RAs@NPs-WYRGRL did not show obvious toxicity in long-term treatment, indicating its good biological safety and suggesting it as a safe and effective treatment strategy for RA

If you prefer to avoid needles, Daytryp even has Tirzepatide Sublingual Drops a needle-free alternative that delivers tirzepatide under the tongue

Dispose of used (and expired) supplies carefully

2026/04/02 10 WEB24 GLP-1 20264NEJM 20264 GLP-1 BMJ Medicine 2026 SURMOUNT-4 eClinicalMedicine 2026 New England Journal of MedicineNEJM202642 GLP-1 GLP-1 Rosen CJ, Ingelfinger JR

Additionally, understanding the vitamin supplementation needs during GLP-1 therapy can help prevent nutritional deficiencies that contribute to side effects

In a resignation message shared publicly by the president, Makary defended his record, citing what he described as dozens of major reforms, including sharply shortened drug review timelines, new guidance for psychedelic therapies, a plausible mechanism pathway for rare disease drugs, and changes to estrogen labelling